Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-16

Clinical Trial Update: Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating ticagrelor and preconditioning in patients with myocardial ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: Italo Porto | Conditions: Myocardial Ischemia | Phase 2, Phase 3 | Status: COMPLETED